47.2, 48.5, 49.4, 49.5, 55.4, 162.2, 167.5. m/z (EI) = 249 (Mϩ ),
Synthesis of 14C-labelled advanced precursors
ؒ
ؒ
204 (100%), 161, 133, 106, 41. m/z (EI) 249.2089 [Mϩ
]
Synthesis of [14C]2-bisisothiocyanatoadociane (17). Hydrolysis
of diisocyanoadociane (1) to bisamine 4. Diisocyanoadociane
(1) (500 mg, 1.54 mmol) was hydrolysed with hydrochloric acid
(6 M, 3 mL) as described above to give bisamine 4 (319 mg,
68%).
C16H27NO requires 249.2092.
Conversion of 9-isothiocyanatopupukeanane (11) to diethyl-
thiourea 15. 9-Isothiocyanatopupukeanane (11) (2.8 mg, 13.9
µCi mmolϪ1) was refluxed in diethylamine (2.5 mL) overnight,
then evaporated. Silica chromatography gave a residue (2.7 mg)
which was purified using normal phase HPLC (5% EtOAc in
Formylation of bisamine 4 to give [14C]2-bisformamide 2.
Sodium formate (400 µCi) was equilibrated with formic acid
(17.7 µL, 0.46 mmol) and added to pivaloyl chloride (69.4 µL,
0.56 mmol) in dry THF (3 mL) and triethylamine (92 µL, 0.66
mmol) and cooled to Ϫ80 ЊC. Bisamine 4 (80.4 mg) in dry THF
(3 mL) was then added, and the reaction mixture allowed to
warm to room temperature. To ensure complete reaction a fur-
ther amount of pre-prepared pivalic formic anhydride (formic
acid (31.9 µL, 0.84 mmol) and pivaloyl chloride (123 µL, 1.0
mmol)) was added at Ϫ80 ЊC, and the reaction again allowed to
warm to room temperature. The reaction mixture was diluted
with CH2Cl2 (10 mL) then washed with sodium hydroxide solu-
tion (10 mL, 2.5 M) followed by sulfuric acid (10 mL, 25%),
then dried and evaporated. Purification by silica chromato-
graphy (eluting with CH2Cl2, then EtOAc stepwise to MeOH)
gave [14C]-labelled bisformamide 2 (105.3 mg, 110%; 120 µCi,
30%). The >100% recovery presumably results from the hygro-
scopic nature of 2; further efforts to purify this material were
not worthwhile at this point.
hexane) giving thiourea 15 (1.8 mg, 50.6%; 14.8 µCi mmolϪ1
,
106%; see footnote to Table 3). δH 0.80 (3H, s), 0.83 (3H, d,
J 7.8), 0.84 (3H, d, J 7.9), 0.98 (3H, s), 1.09 (1H, m), 1.14 (1H,
m), 1.23 (6H, t, J 7.0), 1.24 (1H, m), 1.26 (1H, m), 1.28 (1H, m),
1.30 (1H, m), 1.37 (1H, m), 1.45 (1H, m), 1.48 (1H, m), 1.84
(1H, dd, J 13 and 11), 2.07 (1H, m), 2.47 (1H, m), 3.65 (4H, q,
J 7), 4.34 (1H, m), 5.40 (1H, br d, J 8). δC 12.9, 21.6, 21.8, 24.7,
27.1, 29.2, 30.0, 31.7, 34.2, 38.3, 38.7, 44.1, 45.0, 48.5, 48.7,
49.3, 57.2, 179.9. m/z (ESI) 337.3 (M ϩ Hϩ, 100%). m/z (EI)
337.2684 C20H37N2S requires 337.2677.
Reduction of 2-thiocyanatoneopupukeanane (12) to thiol 16.
2-Thiocyanatoneopupukeanane (12) (6.8 mg, 0.025 mmol, 1.23
µCi mmolϪ1) in dry THF (1.2 mL) was added to LiAlH4 (4.9
mg, 0.13 mmol) and stirred at room temperature for 8 minutes,
then poured into saturated aqueous ammonium chloride
(5 mL) and extracted with EtOAc (3 × 10 mL), dried over
anhydrous magnesium sulfate and evaporated to give 6.6 mg of
a residue. Purification by silica chromatography followed by
normal phase HPLC (0.05% EtOAc in hexane) gave thiol 16
(2.4 mg, 39%; 0.001 µCi mmolϪ1, 0.1%).17 δH 0.78 (3H, d, J 6.5),
0.86 (2H, m), 0.89 (3H, d, J 6.5), 0.92 (1H, m), 0.95 (1H, m),
1.00 (3H, s), 1.05 (3H, s), 1.20 (1H, m), 1.25 (1H, m), 1.34 (1H,
m), 1.38 (1H, m), 1.42 (1H, m), 1.50 (1H, m), 1.78 (1H, ddd,
J 3.5, 11.0 and 14.5), 2.10 (1H, ddd, J 5.5, 9.5 and 14.5), 2.80
(1H br d, J 7). δC 20.9, 21.3, 22.1, 26.3, 26.7, 32.2, 32.2, 32.7,
Dehydration of [14C]2-bisformamide
2
to give [14C]2-
diisocyanoadociane (1). The labelled bisformamide 2 (105.3
mg, 0.29 mmol, 120 µCi) was dissolved in dry pyridine (2 mL)
and added to toluenesulfonyl chloride (332 mg, 1.75 mmol) and
refluxed for 3 h during which time the initially formed purple
colour faded to a light brown. The reaction mixture was poured
into hexane (10 mL), washed with sodium hydroxide solution
(10 mL, 2.5 M) to remove unreacted toluenesulfonyl chloride,
followed by sulfuric acid (2 × 10 mL, 25%) to remove pyridine,
then dried and evaporated. Purification by silica chromato-
graphy (eluting with hexane to CH2Cl2 stepwise then EtOAc)
followed by recrystallisation from hexane gave diisocyanide 1
(36.0 mg, 38%; 68.6 µCi, 57%).
37.9, 39.5, 40.9, 45.7, 44.6, 50.5, 53.3. m/z (EI) 238 (Mϩ ), 223,
ؒ
205 (100%), 149, 107, 95, 41.
[14C]-Thiocyanate and Axinyssa n.sp. The incorporation of
NaS14CN (25 µCi) was performed in the same way using
Axinyssa n.sp. (77 g wet wt.) in 200 mL of seawater. After a
16 day incorporation, the sponge was extracted to give
Reaction of [14C]2-diisocyanoadociane (1) with sulfur to give
[14C]2-bisisothiocyanatoadociane (17). The labelled diiso-
cyanide 1 (36.0 mg, 0.11 mmol, 68.6 µCi) was added to sulfur
(25 mg, 0.78 mmol) in a reaction vial and heated at 120 ЊC
overnight, after which time TLC analysis indicated no remain-
ing starting material. The reaction mixture was chromato-
graphed on a silica PTLC plate to give [14C]2-bisisothiocyanate
17 (17.2 mg, 40%; 23 µCi, 33 %). δH 0.65 (1H, ddd, J 10, 10 and
10), 0.74 (1H, m), 0.82 (1H, m), 0.84 (1H, m), 0.85 (3H, d,
J 6.5), 0.91 (1H m), 0.99 (3H, d, J 6.6), 1.01 (1H, m), 1.08 (2H,
m), 1.09 (1H, m), 1.10 (1H, m), 1.23 (1H, m), 1.26 (3H, s), 1.36
(3H, s), 1.38 (1H, m), 1.42 (1H, m), 1.50 (1H, m), 1.53 (1H, m),
1.77 (1H, ddd, J 13.4, 13.4 and 3.8), 1.87 (1H, dddd, J 13.6, 3.6,
3.6 and 3.6), 1.94 (1H, m), 1.98 (1H, m), 2.05 (1H, m). δC 16.4,
19.6, 20.4, 23.7, 25.6, 26.1, 26.2, 36.4, 38.2, 40.6, 40.7, 41.6,
42.2, 45.9, 46.6, 47.7, 49.0, 50.2, 64.4, 67.9, 130.0, 130.5. m/z
9-isocyanopupukeanane (10) (27.9 mg, 0.036%; 30 dpm mgϪ1
,
0.0015%), 2-thiocyanatoneopupukeanane (12) (12.9 mg,
0.017%; 1255 dpm mgϪ1, 0.029%) and 9-isothiocyanato-
pupukeanane (11) (8.8 mg, 0.011%; 22000 dpm mgϪ1, 0.35%).
Another piece of sponge (24 g) was treated identically with
NaS14CN (12.5 µCi). After a 3 day incorporation period, the
sponge was worked up to give 9-isocyanopupukeanane (10)
(11.1 mg, 0.046%; 19 dpm mgϪ1, 0.0075%), 2-thiocyanato-
neopupukeanane (12) (4.3 mg, 0.0018%; 3036 dpm mgϪ1
,
0.047%) and 9-isothiocyanato-pupukeanane (11) (5.9 mg,
0.024%; 53500 dpm mgϪ1, 1.14%).
Hydration of 9-isocyanopupukeanane (10) to formamide 14.
9-Isocyanopupukeanane (10) (7.4 mg, 0.0032 µCi mmolϪ1) was
treated with acetic acid (2 mL) as before and gave formamide 14
(6.9 mg, 87%; 0.0030 µCi mmolϪ1, 94%).
Conversion of 9-isothiocyanatopupukeanane (13) to diethyl-
thiourea 15. 9-Isothiocyanatopupukeanane (11) (4.0 mg, 2.6
µCi mmolϪ1) was refluxed in diethylamine as before to give
thiourea 15 (2.4 mg, 47%; 2.7 µCi mmolϪ1, 104%; see footnote
to Table 3).
(EI) 388 (Mϩ ), 345, 330, 271 (100%), 201, 55, 41. m/z (EI)
ؒ
388.2001 [Mϩ ] C22H32N2S2 requires 388.2006. This sample was
ؒ
split and used in two incorporation experiments at Lizard
Island.
Reduction of 2-thiocyanatoneopupukeanane (12) to thiol 16.
2-Thiocyanatoneopupukeanane (12) (4.1 mg, 0.015 mmol,
0.15 µCi mmolϪ1) in dry THF (1.2 mL) was added to LiAlH4
(2.9 mg, 0.076 mmol) and stirred at room temperature for
8 minutes, then poured into saturated aqueous ammonium
chloride (5 mL) and extracted with EtOAc (3 × 10 mL), dried
and evaporated to give 4.8 mg of a residue. Purification by silica
chromatography followed by normal phase HPLC (0.05%
EtOAc in hexane) gave thiol 16 (1.6 mg, 44%; 0.0005 µCi
mmolϪ1, 0.3%).
Degradation of synthetic [14C]2-diisocyanoadociane (1).
Hydration of diisocyanoadociane (1) to bisformamide 2. A small
sample (<0.1 mg) of synthetic [14C]-diisocyanoadociane (1) was
diluted with unlabelled material, then recrystallised before use
in degradation studies. The resulting diisocyanoadociane (1)
(7.1 mg, 0.022 mmol, 0.065 µCi mmolϪ1) was treated with
glacial acetic acid as before and gave bisformamide 2 (6.9 mg,
88%; 0.061 µCi mmolϪ1, 94.5%).
Hydrolysis of [14C]2-bisformamide 2 to [14C]-monoamine 3.
Bisformamide 2 (6.7 mg, 0.019 mmol; 0.061 µCi mmolϪ1) was
O r g . B i o m o l . C h e m . , 2 0 0 4 , 2, 9 3 9 – 9 4 8
946